loadpatents
Patent applications and USPTO patent grants for Li; Guangnan.The latest application filed is for "combinations of engineered natural killer cells and engineered t cells for immunotherapy".
Patent | Date |
---|---|
Combinations Of Engineered Natural Killer Cells And Engineered T Cells For Immunotherapy App 20220233593 - Trager; James Barnaby ;   et al. | 2022-07-28 |
Methods For The Simultaneous Expansion Of Multiple Immune Cell Types, Related Compositions And Uses Of Same In Cancer Immunotherapy App 20220047635 - LIU; Daofeng ;   et al. | 2022-02-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.